CompatibilitĂ
Salva(0)
🌍 Investing in Innovation & International Growth
We’re thrilled to see our portfolio company LABOMAR Group take another bold step in its international expansion with the acquisition of Pharmia Oy, a Finnish leader in nutraceuticals and CE-certified medical devices.
🇮🇹🤝🇫🇮
This strategic move strengthens Labomar’s footprint in Northern Europe – one of the fastest-growing markets for health and wellness – and reinforces the Group’s commitment to building a truly global, innovative ecosystem.
Cleon Capital
